We are live on ! Find out more
SWTX

SpringWorks Therapeutics

Delisted

SWTX was delisted on the 30th of June, 2025.

148 hedge funds and large institutions have $1.64B invested in SpringWorks Therapeutics in 2022 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 56 increasing their positions, 44 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

939% more call options, than puts

Call options by funds: $20.8M | Put options by funds: $2.01M

75% more funds holding in top 10

Funds holding in top 10: 47 (+3)

35% more capital invested

Capital invested by funds: $1.21B → $1.64B (+$428M)

32% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 19

27% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 44

3% more funds holding

Funds holding: 143148 (+5)

10.49% less ownership

Funds ownership: 111.87%101.38% (-10%)

Holders
148
Holders Change
+5
Holders Change %
+3.5%
% of All Funds
2.55%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.12%
New
25
Increased
56
Reduced
44
Closed
19
Calls
$20.8M
Puts
$2.01M
Net Calls
+$18.8M
Net Calls Change
+$19.4M
Name Holding Trade Value Shares
Change
Change in
Stake
Principal Financial Group
101
Principal Financial Group
Iowa
$273K +$275K +9,575 New
Teacher Retirement System of Texas
102
Teacher Retirement System of Texas
Texas
$254K +$255K +8,897 New
YIH
103
Y-Intercept (HK)
Hong Kong
$248K +$249K +8,685 New
OAM
104
Oppenheimer Asset Management
New York
$237K -$10.7K -372 -4%
QT
105
Quantamental Technologies
New York
$229K +$230K +8,011 New
ProShare Advisors
106
ProShare Advisors
Maryland
$227K +$229K +7,977 New
ASRS
107
Arizona State Retirement System
Arizona
$211K +$212K +7,385 New
XT
108
XTX Topco
Cayman Islands
$204K +$205K +7,135 New
O
109
OrbiMed
New York
$158K -$14.4M -502,381 -8%
QT
110
Quantbot Technologies
New York
$156K +$158K +5,500 New
Ensign Peak Advisors
111
Ensign Peak Advisors
Utah
$149K -$2.02M -70,499 -93%
VEA
112
Virtus ETF Advisers
New York
$147K +$1.15K +40 +0.8%
ACP
113
Acuta Capital Partners
California
$143K
AB
114
Amalgamated Bank
New York
$132K +$459 +16 +0.3%
Public Employees Retirement Association of Colorado
115
Public Employees Retirement Association of Colorado
Colorado
$131K
Zurich Cantonal Bank
116
Zurich Cantonal Bank
Switzerland
$128K +$128K +4,480 New
Federated Hermes
117
Federated Hermes
Pennsylvania
$120K -$602 -21 -0.5%
AssetMark Inc
118
AssetMark Inc
California
$94K +$42.8K +1,494 +82%
US Bancorp
119
US Bancorp
Minnesota
$87K -$5.05K -176 -5%
VIA
120
Virtus Investment Advisers
Connecticut
$79K +$78.9K +2,752 New
AIP
121
Ameritas Investment Partners
Nebraska
$75K
Amundi
122
Amundi
France
$75K
TRCT
123
Tower Research Capital (TRC)
New York
$74K -$330K -11,493 -82%
Osaic Holdings
124
Osaic Holdings
Arizona
$58K +$16.5K +576 +39%
MLICM
125
Metropolitan Life Insurance Company (MetLife)
New York
$54.4K

SWTX Hedge Fund Activity: Q3 2022 in Review

148 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q3 2022, worth a combined $1.64B — up 35% from $1.21B a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new SWTX positions and 19 closed out — a net gain of 6 holders — while 56 added to existing stakes and 44 trimmed.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $99.2M. The largest seller was Driehaus Capital Management, cutting an estimated $25.6M.

  • 148 institutional investors held SpringWorks Therapeutics (SWTX) as of Q3 2022, up from 143 in Q2 2022.
  • Funds reported $1.64B of SpringWorks Therapeutics stock for Q3 2022, up 35% quarter-over-quarter.
  • 25 funds opened new SpringWorks Therapeutics positions in Q3 2022 and 19 closed out, a net change of +6 holders.
  • The largest SpringWorks Therapeutics buyer in Q3 2022 was EcoR1 Capital, an estimated $99.2M added.
  • The largest SpringWorks Therapeutics seller in Q3 2022 was Driehaus Capital Management, an estimated $25.6M sold.

Based on aggregated 13F filings for Q3 2022.